Established in 1991, Thind Eye Hospital has built a strong reputation for clinical excellence, technological leadership, and compassionate patient care. With over three decades of service and innovation, the hospital continues its mission of delivering world-class eye care with international standards across Punjab.

The Ludhiana expansion marks a significant milestone in the hospital’s growth strategy, ensuring that patients in Punjab’s largest industrial and educational hub have direct access to advanced ophthalmic treatments without the need to travel outside the city.

The institution is led by Dr. Jaswant Singh Thind, Chairman and Chief Eye Surgeon, a pioneer in refractive and cataract surgery with more than 38 years of surgical experience.

He is recognized as the first in India to perform the highest number of ICL, LASIK, and SMILE procedures and the first in North India to introduce LASIK in 1998.

He has also pioneered blade-free cataract surgery in the region and is a member of leading international societies including the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgeons.

Thind Eye Hospital is a NABH-accredited super-specialty eye hospital and has been listed among the Top 10 Eye Hospitals in India by ICHA. The hospital is known for introducing advanced technologies such as high-precision excimer lasers, sutureless vitrectomy, topical anesthesia cataract surgery, and minimally invasive surgical techniques.

The Ludhiana center will provide comprehensive eye care under one roof, including:

• Refractive Surgery – LASIK, SMILE PRO, Customized LASIK
• 100 percent blade-free Cataract Surgery
• Retina and Vitreoretinal Services
• Diabetic Retinopathy Management
• Glaucoma Treatment
• Cornea and Keratoconus Management including C3R
• Pediatric Ophthalmology and Squint Treatment
• Oculoplasty and Neuro-Ophthalmology

Over the years, Thind Eye Hospital has served patients not only from across India but also from the United States, Canada, Europe, Australia, Asia, and the Middle East, establishing a strong global reputation for outcomes and patient satisfaction.

Beyond surgical excellence, the hospital remains committed to community outreach through rural eye camps, school eye health programs, and a policy that ensures treatment is never denied to a needy patient.

With existing branches in Jalandhar, Hoshiarpur, and Pathankot, the launch in Ludhiana further strengthens Thind Eye Hospital’s regional presence and reinforces its commitment to accessible, high-quality eye care across Punjab.

For further information, media inquiries, or appointment details,

Please contact:

Thind Eye Hospital

Email:

thind701@gmail.com
thindeyehospital@gmail.com

Contact No:

+91 88720 70022 (Jalandhar)
+91 95940 50391 (Ludhiana)

The post Thind Eye Hospital Expands to Ludhiana, Bringing Advanced Super-Specialty Eye Care to Punjab’s Largest City appeared first on World Circular.

In an in-depth interaction, founders Dr. Geetendra Singh Dhanawat and Dr. Narendra Singh Chandel shared their vision of creating a globally trusted, doctor-backed skincare ecosystem that integrates dermatological science with modern lifestyle needs.

Global Skincare Industry Entering a Science-Driven Phase

The global dermocosmetics and preventive skincare sector is witnessing strong expansion as consumers demand clinically credible and dermatology-recommended products. Industry analyses suggest that the global dermocosmetics market is expected to surpass USD 80–100 billion in the coming decade, driven by rising awareness about skin health, environmental damage, and sensitive skin concerns.

India, in particular, is emerging as one of the fastest-growing skincare markets globally. The country’s beauty and personal care sector is projected to grow steadily over the next decade, with premium and dermatology-driven skincare seeing significant momentum due to urbanization, pollution exposure, and growing consumer education around preventive skin health.

These trends are reshaping the industry from cosmetic-centric offerings toward evidence-based, doctor-guided skincare solutions.

“Skincare Must Move from Cosmetic Routine to Preventive Health”

— Dr. Geetendra Singh Dhanawat

According to Dr. Geetendra Singh Dhanawat, physician-entrepreneur and founder of Episenz Skin Science, the future of skincare will be defined by prevention rather than correction.

“The skin is constantly exposed to UV radiation, pollution, heat, and lifestyle stress. Yet most people still treat skincare as occasional cosmetic care. The next evolution of skincare is preventive — protecting and strengthening skin continuously before damage accumulates,” he said.

Dr. Geetendra believes that as awareness grows, consumers will increasingly look for doctor-backed, science-driven solutions that offer safety, credibility, and measurable outcomes.

“We are building Episenz as a preventive skin health company. Our long-term vision is to create a trusted global platform that blends dermatological science with everyday usability — making skin protection and recovery a continuous process rather than an occasional intervention,” he added.

A Strong Clinical and Strategic Foundation

Co-founder Dr. Narendra Singh Chandel brings decades of clinical experience along with a deep understanding of healthcare and pharmaceutical ecosystems. He emphasized that the brand’s approach is rooted in medical science and long-term credibility.

“Consumers today are far more informed. They want transparency, safety, and evidence-based formulations. The gap between cosmetic claims and clinical credibility is becoming more visible. We see a strong opportunity to build a brand that bridges that gap with integrity and science,” Dr. Chandel said.

The founding team combines extensive medical expertise with entrepreneurial and operational experience across healthcare, education, and global supply networks — creating a strong foundation for scalable growth in the dermatology-driven skincare segment.

India as a Strategic Launchpad for Global Expansion

The founders view India not only as a large consumer market but also as a strategic innovation hub for dermatology-led skincare solutions.

“India presents one of the most demanding environments for skin — high UV exposure, pollution, and climate variability. If a preventive skincare system proves effective here, it has strong relevance globally,” said Dr. Geetendra.

Episenz is being built with preventive care-first and globally scalable mindset. The company aims to establish a strong presence in urban and premium skincare segments while building credibility through dermatology professionals, clinical collaborations, and education-driven outreach.

Over time, the brand plans to expand into international markets with similar environmental exposure patterns and growing demand for preventive skincare.

Building Trust Through Science, Education, and Consistency

The founders emphasize that long-term success in the modern skincare industry will depend on trust, transparency, and continuous innovation.

“The future belongs to brands that educate, not just advertise. Consumers are looking for reliable guidance on how to protect their skin in a high-stress, high-exposure world. We want Episenz to become a trusted voice in preventive skin health,” Dr. Chandel noted.

Rather than focusing on short-term trends, the company is investing in research-based development, clinical insight, and a preventive skincare philosophy designed for everyday life.

A Long-Term Vision for Global Skin Health

As the skincare industry evolves toward science-driven solutions, Episenz Skin Science is positioning itself with a long-term outlook rooted in medical credibility and global relevance.

“We are not just building a product-based company; we are building a skin science platform for the future. Our aim is to create a globally respected, doctor-backed brand that stands for preventive skin health, consistency, and trust,” Dr. Geetendra concluded.

With a strong medical foundation, a clear preventive health philosophy, and alignment with global skincare trends, Episenz Skin Science Private Limited represents a new generation of dermatology-led ventures shaping the future of preventive skincare.

About Episenz Skin Science Private Limited

Episenz Skin Science Private Limited is a doctor-founded dermatology-driven skincare innovation company focused on preventive skin health and science-based formulations. Headquartered in Mumbai, India, the company aims to build a globally trusted skin science platform that integrates dermatological expertise with modern lifestyle needs.

Media Contact:
Episenz Skin Science Private Limited
Mumbai, India
Email: wecare@episenz.com
Website: www.episenz.com

The post Doctor-Founded Episenz Skin Science Emerges with a Preventive Skincare Vision for the Next Decade of Dermatology-Led Consumer Health appeared first on World Circular.

The post Premas Life Sciences Partners with Bruker Spatial Biology to Strengthen Advanced Tissue Research in India appeared first on World Circular.

A new report by Equality Now and the Sexual Violence Prevention Association (SVPA), Online sexual exploitation and abuse in the United States: An analysis of policy gaps, system response and prevention mechanisms through survivor-lived experiences, draws on survivor insights and expert legal analysis to identify harms arising from OSEA and provide evidence-based recommendations for legal and policy reform.

Survivors described navigating a confusing patchwork of federal and state laws that make access to justice and support difficult, while tech companies face minimal legal obligations to act decisively. Online platforms are often slow and ineffective in responding to requests to remove abusive content, leaving non-consensual sexual material to circulate indefinitely, causing ongoing harm and retraumatization.

Every survivor interviewed suffered repeated reposting of abusive material across multiple platforms, and none succeeded in having content removed entirely. No perpetrators were held fully to account, and for those who faced any consequences, these were limited to the initial posting of material, failing to reflect OSEA’s ongoing nature and revictimisation.

Gaps and inconsistencies in laws on online sexual exploitation and abuse

Legal protections against OSEA in the US are split between federal and state systems, each with its own laws, courts, and areas of authority. Federal laws on tech-facilitated abuse are not comprehensive, and while states provide additional protections, the jumble of laws across jurisdictions complicates cases and creates legal loopholes. Concerningly, there are virtually no laws spanning international borders that address OSEA involving adult victims.

State laws are often unclear and vary widely, resulting in inconsistent responses and protections that depend on where someone lives. Poor coordination and communication between states and across levels of government further undermine survivors’ access to timely, meaningful assistance.

OSEA often involves multiple platforms and offenders in different jurisdictions. This creates confusion about which laws apply and what authorities have the power to act, and survivors lack knowledge about how to report violations and preserve evidence.

Only 45 states have updated their laws to cover AI-generated child sexual abuse imagery (CSAM), while protections for adults lag even further behind. State-level coverage remains patchy with penalties for nonconsensual AI-generated or computer-edited sexually explicit materials – often called deepfakes – ranging from a misdemeanor to felony.

Existing data doesn’t capture OSEA’s rapid evolution and scale. With research and reporting focused primarily on CSAM, adult survivors remain largely invisible, contributing to inadequate responses from lawmakers. Better data collection and reporting are urgently needed to close research gaps and ensure legislation keeps pace with technological developments.

Holding tech companies accountable for OSEA on their platforms

No US statute expressly requires US-based tech companies to maintain user safety and transparency, and only limited duties are placed on them to prevent and protect against tech-facilitated abuse. Policies must be created and enacted to hold tech companies accountable for the nonconsensual publication and distribution of sexually explicit materials on their platforms.

The “Big Five” US-based corporations – Alphabet (Google), Amazon, Apple, Meta, and Microsoft – dominate global digital markets and control the primary platforms through which OSEA occurs. In 2020 alone, their combined market value reached $7.5 trillion, giving them unprecedented power to shape global standards for digital safety, content moderation, and transparency.

Survivors described multiple challenges when dealing with tech platforms. They found it difficult to locate reporting systems, responses were inconsistent and inadequate, and moderation or content removal erased critical evidence, undermining legal investigations.

Interviewees developed informal routines to monitor digital spaces and submit so-called “takedown requests.” These must often be filed repeatedly, sometimes daily, and survivors can wait months or even years for a response. In several cases, platforms eventually said no action could be taken.

One interviewee, Izzy, and her partner sent intimate images to each other via Snapchat. Her account was hacked, and her images, name, and address were sold to pornography websites. Izzy’s family was sent the content and threatened that it would be circulated further unless they paid. Izzy recalled Snapchat’s response, “Within their community guidelines, they say you’re not supposed to take any sexually explicit pictures of yourself, so if anything does happen to you, that’s your fault. It genuinely made me sick to my stomach how dismissive they were!”

Equality Now’s Anastasia Law explains, “US laws have failed to keep pace with the realities of tech-facilitated sexual abuse, and survivors are paying the price. With no US federal statute requiring tech companies to ensure user safety or transparent reporting systems, survivors must navigate outdated laws, inconsistent responses, and repeated obstacles when trying to take down abusive material or hold perpetrators accountable.”

“Lawmakers must act to strengthen state and federal laws, with clear policies governing consent and the online distribution of sexual material in an increasingly borderless digital world. US-based tech companies need to be held fully accountable for the non-consensual publication and spread of sexually explicit content on their platforms.”

Survivors face systemic failures when reporting tech-facilitated sexual abuse

Every survivor in the study who formally reported their abuse found the experience overwhelmingly negative. They had to educate themselves about complex legal systems, sort evidence, and coordinate between platforms and agencies. Survivors found law enforcement officials unclear and uncertain about “takedown request” procedures, handling digital evidence, and evidence-collection protocols, including obtaining warrants, issuing subpoenas, and determining admissibility of online materials.

This extended to prosecutors, attorneys, judges, and even victim advocates. Criminal justice professionals typically didn’t know the relevant statutes, with survivors often required to identify remedies and coordinate between the criminal and civil systems.

Survivors frequently encountered victim-blaming, and their experiences were often dismissed or minimised. Many were questioned about their consent and credibility, portrayed as overly emotional or unreliable, and excluded from key decisions affecting their cases.

Online sexual exploitation and abuse harm survivors in multiple ways

OSEA survivors face an increased risk of physical harm, including domestic abuse, sexual violence, and human trafficking. They often experience psychological problems associated with in-person sexual violence, such as shame, anger, social withdrawal, fatigue, anxiety, increased substance use, and engagement in risky behaviours. Research participants all experienced significant emotional harm, including hopelessness and depression, with four having suicidal thoughts.

Samantha had a video posted online of her being raped by a male police officer. She explained, “It’s one thing that the attack happened, but then, when it was shared to be rewatched over and over again, and I had no control over how far it was reaching, or how many people were viewing it, or who had access to it… It emotionally was just horrifying.”

Interviewees described living in constant fear about meeting people who’ve seen the abusive content, that more material could surface, or they or their families could be threatened. They also reported profound feelings of betrayal and trust issues with partners and others – of the 13 survivors interviewed, five were in committed, in-person relationships with the person who abused them.

Another burden was the financial cost. Many survivors paid for legal services, but for some, it was unaffordable, leaving them to navigate complex legal processes alone. Several spent thousands on mental health counseling, and some incurred costs from relocating due to safety concerns.

Three interviewees lost their jobs outright, while four others lost career advancement opportunities. Izzy was harassed on LinkedIn by people who’d seen her on pornographic sites, and she now pays $1,000 a month to a private company to find and remove OSEA content.

Katie Knick from SVPA concludes, “Online sexual exploitation and abuse is a form of systemic sexual violence rooted in misogyny, racism, and other intersecting oppressions. While technology shapes how the harm occurs, prevention depends on dismantling rape culture and reducing power imbalances through education, policy reform, and institutional accountability.”

“Our research underscores the need for survivor-centered systems, including free legal representation, trauma-informed mental health care, specialized professional training, and clear pathways for reporting and removal of abusive material. Sustainable prevention requires accountability and policies informed by the voices and leadership of survivors with lived experience.”

END

Notes to editors: For media enquiries, contact Tara Carey, Global Head of Media, Equality Now, Tcarey@equalitynow.org, T. +44 (0)7971556340 (available on WhatsApp and Signal)

This report on online sexual exploitation and abuse in the US is the third in a trilogy by Equality Now and its partners, documenting survivors’ experiences, identifying gaps in legal protections and barriers to justice, and setting out evidence-based recommendations for legal and policy reform. The other reports focus on India and Kenya:

• Experiencing Online Sexual Exploitation and Abuse in Kenya: Survivor Narratives and Legal Responses
• Experiencing Technology-Facilitated Gender-Based Violence in India: Survivor Narratives and Legal Responses

About: Equality Now is a worldwide human rights organization dedicated to securing the legal and systemic change needed to end discrimination against all women and girls. Since its inception in 1992, it has played a role in reforming 120 discriminatory laws globally, positively impacting the lives of hundreds of millions of women and girls, their communities, and nations.

About: The Sexual Violence Prevention Association (SVPA) is a nonprofit dedicated to preventing sexual violence systemically. Our work spans legislative advocacy, research, public education, and institutional engagement. Led my marginalized survivors, SVPA believes that by challenging harmful behaviors, and advocating for policies that prioritize safety and respect, we can prevent sexual violence systemically and create a safer, more equitable society.

The post Survivors of online sexual abuse in the US face legal gaps and inaction by tech companies, new report finds appeared first on World Circular.

The post HARLEY of LONDON India to Launch Global Centre of Excellence for Health, Wellness & Lifestyle in Chandigarh appeared first on World Circular.

The post Meducination and Ujala Cygnus Launch Clinical Observership Programs to Strengthen Practice-Readiness of Medical Graduates appeared first on World Circular.

The ventilators were formally handed over during a ceremonial event held at the ICH Auditorium, in the distinguished presence of District Governor Rtn. Vinoth Saraogi (District 3234). The occasion was further graced by RCMS President Rtn. R. Rajanbabu, Secretary Rtn. Sibi Rajan, and Rtn. K. Saravanan, Director – Community Services Health, in the presence of few more rotarians & Ann’s from RCMS, who officially handed over the equipment.

The hospital leadership was represented by Dr. Madhivanan, Director of Health, ICH, and Dr. G. K. Jaikaran, Professor and Head, Paediatric Cardiothoracic and Vascular Surgery, ICH, who acknowledged the timely and impactful contribution that will significantly strengthen pediatric critical care services at the institution.

Demonstrating a deep commitment beyond equipment donation, RCMS has ensured a comprehensive 5-year Annual Maintenance Contract (AMC) for both ventilators and has also set aside dedicated funds to address any unforeseen repair or operational expenses. This thoughtful approach ensures uninterrupted, long-term functionality of the life-saving equipment.

Speaking on the occasion, RCMS leaders emphasized that the “Save Lives” project stands as one of the most prestigious and meaningful initiatives of RCMS in the current Rotary year, reflecting the club’s sustained focus on child healthcare and preventive support systems.

“This initiative goes beyond a donation—it is a promise of continuity, care, and responsibility towards saving young lives,” said a senior RCMS office bearer.

With this project, Rotary Club of Madras South once again reaffirmed its commitment to Rotary International’s theme “Unite for Good,” reinforcing the belief that impactful service, when thoughtfully executed, can truly transform lives.

For media enquiries, please contact:
Balamurugan S
Chairman – Public Image
rtnbalasubbiah@gmail.com

The post RCMS Donates Advanced Pediatric Ventilators to Institute of Child Health, Egmore appeared first on World Circular.

Triokris

Wilson’s Disease is a progressive condition that, if untreated, can lead to severe hepatic, neurological, and psychiatric complications due to toxic copper accumulation. Early diagnosis and long-term treatment are critical for achieving meaningful clinical outcomes.

Triokris (Trientine Dihydrochloride) is recognized internationally as a well-established chelating agent with a long-standing clinical history. It is widely used across the United States, Europe, India, and multiple global regions for the management of Wilson’s Disease. The formulation is known for its stability profile and predictable absorption characteristics.

Intended Audience Notice: This announcement is intended for healthcare professionals, hospitals, and authorized importers involved in the treatment and management of Wilson’s disease.

Key Highlights:

• Triokris (Trientine Dihydrochloride 250 mg) is now available via Named Patient import pathways
• Supports patients with Wilson’s disease who are intolerant to first-line therapy
• Supplied under full regulatory compliance with complete quality documentation
• Backed by GDP-aligned global logistics and pharmacovigilance oversight

Commitment to Rare Disease Care

Addressing the importance of patient access, Mr. Praveen Sikri, Founder & CEO, and Mr. Bharat Sikri, Director of Ikris Pharma Network, stated:

“Our focus has always been on supporting physicians and hospitals managing complex and rare conditions. With Triokris, we are helping enable access to a globally trusted chelation therapy for patients living with Wilson’s Disease, through compliant and well-structured pathways.”

Through its global sourcing network and regulatory-compliant import pathways, Ikris Pharma Network facilitates access to essential therapies in alignment with the Drugs & Cosmetics Act, ensuring product authenticity, full documentation, and cold-chain integrity where required.

About Triokris (Trientine Dihydrochloride)

Triokris is an oral chelating agent used for the removal of excess copper from the body. It is typically considered in:

• Patients with intolerance to D-Penicillamine
• Patients requiring maintenance therapy
• Clinical scenarios where a stable, predictable chelator is preferred

The formulation consists of 250 mg of Trientine Dihydrochloride, developed to meet internationally accepted quality standards. Triokris is not intended to replace the clinical judgment of healthcare professionals, and treatment decisions should always be guided by a physician experienced in managing Wilson’s Disease.

Strengthening Access Through Regulatory Compliance

Ikris Pharma Network operates under strict adherence to Indian regulatory frameworks, ensuring that medicines supplied under the Named Patient Import Program follow mandated approval processes, documentation, batch traceability, and patient safety safeguards.

The organization collaborates with global manufacturers and GDP-compliant logistics partners to maintain integrity from dispatch to delivery. Each supply is backed by relevant quality documents.

A Step Forward for the Wilson’s Disease Community

The introduction of Triokris underscores Ikris Pharma Network’s mission to improve treatment access for underserved patient populations. The company continues to work closely with hepatologists, neurologists, rare disease centers, and patient support groups to strengthen awareness and early management of Wilson’s Disease.

About Ikris Pharma Network

Ikris Pharma Network is a global pharmaceutical services organization specializing in Named Patient Access, Rare Disease Medicines, Generic Medicine Export, RLD/Comparator Drug Supply, and Clinical Trial Support. The company partners with hospitals, physicians, and leading pharmaceutical manufacturers across the world to enable compliant access to hard-to-find therapies worldwide.

The company operates from its global headquarters in India and has established offices in Belgium, Bulgaria, and Hong Kong, supported by two strategic pharmaceutical warehouses in Europe. Ikris ensures end-to-end regulatory compliance, GDP-aligned supply-chain operations, and robust pharmacovigilance practices across all markets it serves.

Safety Reporting Information:

For any suspected adverse events or side effects associated with the use of Triokris, healthcare professionals and patients are encouraged to report them by contacting drugsafety@ikrispharmanetwork.com.

Reporting safety information supports ongoing pharmacovigilance activities and helps ensure the continued safe and appropriate use of the medicine.

Disclaimer:

This material is provided for informational purposes only. Triokris is supplied in accordance with applicable regulatory requirements. Treatment decisions must be made by qualified healthcare professionals based on individual patient needs.

Media Contact:

Ikris Pharma Network Pvt. Ltd.
Email: info@ikrispharmanetwork.com
Website: www.ikrispharmanetwork.com
TOLL-FREE: 1800 1200 365

The post Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease appeared first on World Circular.

The newly installed NICU units are designed to support newborns requiring intensive medical attention immediately after birth. These units will provide round-the-clock critical care, advanced respiratory support, and continuous monitoring, enabling early detection and timely management of life-threatening complications. By enhancing hospital infrastructure, the initiative seeks to significantly improve survival outcomes for newborns who otherwise face limited access to specialised neonatal facilities.

Premature birth and neonatal complications remain among the leading causes of infant mortality in India, particularly in low-income and resource-constrained families. Access to NICU facilities plays a crucial role in ensuring safe recovery during the first few days and weeks of life. Through Project MedAssist, Pledge Foundation continues its commitment to bridging healthcare gaps by enabling hospitals to deliver quality medical care to those who need it the most.

The inauguration ceremony was attended by Mr. Sachin Chaudhary, Director of Lasenor India, and Dr. Raj Nagarkar, Managing Director of KIMS Manavata Hospital, Chief of Surgical Oncology & Robotic Services, and Head of HCG Manavata Cancer Centre. Hospital officials, medical staff, and representatives from both organisations were also present during the event.

Speaking on the occasion, Co-founder and Director of Pledge Foundation Mr. Aldrin Alex highlighted the importance of strengthening neonatal healthcare infrastructure at the grassroots level. They reiterated that timely medical intervention during the neonatal stage can prevent long-term health complications and save lives. The foundation emphasised that partnerships with responsible corporate organisations such as Lasenor India play a vital role in scaling sustainable healthcare solutions.

As part of the ceremony, KIMS Manavata Hospital presented an appreciation letter to Pledge Foundation, acknowledging its contribution toward improving neonatal care facilities at the hospital. The recognition reflects the shared commitment of the hospital and the foundation to provide equitable healthcare access and reinforce systems that support vulnerable newborns and their families.

Lasenor India reaffirmed its commitment to supporting healthcare initiatives that create meaningful social impact. The collaboration under Project MedAssist aligns with the company’s focus on community well-being and responsible corporate citizenship through targeted interventions in the healthcare sector.

With this initiative, Pledge Foundation continues to expand its Emergency Medical Care efforts, which focus on providing timely medical support, strengthening hospital infrastructure, and enabling life-saving treatment for children in need. The foundation believes that access to critical care should not be determined by socio-economic circumstances, especially during the most vulnerable stages of life.

About Pledge Foundation

Pledge Foundation is a humanitarian organisation working towards empowering children and women through healthcare initiatives, education support, hunger relief, and emergency medical care. Guided by the belief that access to treatment is a basic human right, the foundation collaborates with hospitals, corporate partners, and communities to deliver sustainable and impactful interventions across India.

Media Contact:

Pledge Foundation

Email: care@pledgefoundation.org

Website: www.pledgefoundation.org

The post Pledge Foundation and Lasenor India Inaugurate NICU Units for Underprivileged Babies at KIMS Manavata Hospital, Nashik appeared first on World Circular.

This expansion reinforces Eskag Sanjeevani’s position as one of India’s leading PPP healthcare operators, delivering affordable excellence to millions of citizens each year. By partnering with state governments and leveraging innovative delivery models, the group continues to make high-quality healthcare accessible to communities that have long remained underserved.

Dialysis and Diagnostics: Expanding Access, Empowering Lives

At the core of Eskag Sanjeevani’s national footprint lies its deep commitment to renal care and diagnostics. Through its 170+ operational Dialysis Centres, the organisation plays a pivotal role in India’s ongoing battle against Chronic Kidney Disease (CKD). These centres ensure that life-saving hemodialysis and related treatments are available closer to patients’ homes, substantially reducing travel burdens and easing pressure on public hospitals.

The establishment of 25 modern diagnostic centres under the PPP model has further strengthened India’s healthcare screening and early detection infrastructure. Equipped with advanced pathology and imaging technologies, these centres provide timely, affordable diagnostic services for a wide range of medical conditions. Collectively, Eskag Sanjeevani’s dialysis and diagnostic facilities have already delivered millions of treatment and testing sessions, representing one of the most impactful PPP healthcare networks in the country.

Multi-Specialty Hospitals: The Core of Comprehensive Care

Complementing its extensive PPP operations, Eskag Sanjeevani operates NABH-accredited Multi-Specialty Hospitals located in Bagbazar, Baranagar, and Khardaha. They also have another branch located at Dainhat. All hospitals serve as tertiary care hubs, offering a full spectrum of super-specialities, including cardiology, orthopaedics, nephrology, critical care, gastroenterology, general surgery and more.

Each hospital is designed as a centre of clinical excellence, staffed with experienced medical professionals and equipped with modern infrastructure to handle complex medical and surgical interventions. Patients from outreach PPP centres are seamlessly referred to these hospitals for advanced treatment, creating a hub-and-spoke model that connects primary access points with tertiary care facilities.

This integrated network ensures continuity of care, enabling Eskag Sanjeevani to offer an end-to-end healthcare ecosystem — from early diagnosis to advanced treatment and recovery — within a single unified system. It exemplifies the group’s commitment to combining technology, compassion, and ethical practice in every stage of care delivery.

Top-Notch Medical Care under One Roof

Eskag Sanjeevani Hospitals offer a full range of healthcare services in many specialities. This ensures patients get complete and professional treatment.

– Cardiology and Cardiothoracic Surgery: Skilled cardiologists lead the advanced cardiology department, which uses tools such as 128-slice cardiac CT scans to diagnose and treat patients.

– Neurosciences: The Neurology and Neurosurgery teams excel in identifying and treating problems like strokes, brain cancer, and severe spinal cord disorders. Their work has set a high standard of success.

– Orthopaedics and Joint Replacement: The orthopaedic unit addresses injuries from accidents to issues related to ageing. They achieve excellent outcomes in modern hip and knee replacement surgeries.

– Gynaecology (Obstetrics and Gynaecology): This department stands out as a leader in women’s health, offering services including pregnancy care, infertility treatment, and complex surgeries. It has gained recognition as Bengal’s first “Mullerian Anomaly Centre” and provides exceptional expertise in reproductive health alongside care for challenging congenital gynaecological disorders.

– Gastroenterology and General Surgery: This team uses advanced tools like Endoscopy and ERCP to diagnose and treat digestive problems. They also focus on performing general and laparoscopic surgeries with small cuts to promote quicker healing.

– Other Major Departments: The hospital group provides similar top-tier services in Nephrology (Kidney), Urology, Oncology (Cancer), Paediatrics (Child), Dermatology (Skin), and Critical Care.

Driving the Future of Healthcare through Partnership

“Our growth is guided by a simple belief — quality healthcare should never be a privilege,” said Mr. Sunil Agarwal, Honourable Managing Director, Eskag Group of Companies. “With over 170 dialysis and 25 diagnostic centres under the PPP model, and four advanced multi-speciality hospitals forming the backbone of our network, we are redefining healthcare access by blending compassion, technology, and partnership.”

The group’s strategic alignment with the Government’s healthcare vision continues to strengthen its leadership position in PPP-based healthcare. By expanding collaborations with central and state health departments, Eskag Sanjeevani plans to further increase its footprint across dialysis, diagnostics, and hospital care in the coming years.

Our New Launch: Advanced Silent MRI at Eskag Sanjeevani Bagbazar

In a significant technological upgrade for 2025, Eskag Sanjeevani Hospital Bagbazar has launched a state-of-the-art 1.5 MRI machine. Designed with patient comfort as a priority, this advanced machine is soundless and non-claustrophobic, drastically improving the patient experience during scans. True to the group’s mission, this premium diagnostic service is being made available at an affordable cost, ensuring that superior diagnostic imaging is accessible to all.

Combining Modern Technology with Compassionate Care

Eskag Sanjeevani Hospitals lead in using cutting-edge medical technology to provide outstanding care. It has modular OTs with clean environments and high-tech labs that help with accurate testing and successful surgeries. Patients in critical condition benefit from continuous care in specialised units such as the ICCU and HDU.

The Bagbazar branch is soon opening a top-notch Cath Lab to expand its heart treatment services. Additionally, in the Neurosurgery department, the advanced Neuro Microscope enhances precision and safety by magnifying delicate brain and spinal structures during complex surgeries.

The real strength lies in the hardworking team. The Bagbazar main branch has a team of over 150 expert doctors, as well as more than 400 trained nurses and support staff. Their combined knowledge, experience, and compassion create the personal care for which Eskag Sanjeevani is known.

Building a Healthier Tomorrow

With sustained investments in medical technology, capacity building, and patient-centric operations, Eskag Sanjeevani remains steadfast in its vision to become India’s most trusted provider of inclusive, ethical, and technologically advanced healthcare.

Every new centre and hospital represents another step toward a single, powerful goal — making world-class healthcare accessible, affordable, and available to every Indian, everywhere.

About Eskag Sanjeevani Hospitals

Established in 2004, Eskag Sanjeevani has emerged as a premium healthcare provider in Kolkata. Dedicated to delivering compassionate medical excellence, we proudly serve the community through our facilities in Bagbazar, Khardah, Baranagar, and Dainhat.

Contact us –

Tel: (+91) 91633 50506

Tel: (+91) 62930 00300

Toll Free: 18002122582

WhatsApp: (+91) 81001 66969

Email: info@eskagsanjeevani.com

Website: www.eskagsanjeevani.com

The post Eskag Sanjeevani Expands to 170+ Dialysis and 25 Diagnostic Centres Nationwide, Setting a New Benchmark for Accessible Healthcare in India appeared first on World Circular.